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Abstract
Background: Transgender people are disproportionately affected by HIV. Despite their high vulnerability to HIV,
lack of adequate epidemiological and surveillance data related to this population in many countries prevents
provision of appropriate services. This paper summarizes descriptive findings from a national integrated biological
and behavioral survey and discusses policy implications of the findings on HIV prevention among transgender
women in Cambodia.
Methods: This cross-sectional study was conducted between December 2015 and February 2016. Participants were
recruited from 20 sites in the capital city and 12 provinces of Cambodia using Respondent Driven Sampling (RDS)
method. Behavioral data were collected through structured questionnaire interviews, and rapid finger-prick HIV testing
was performed. Descriptive data analyses were conducted using STATA.
Results: This study included 1,375 transgender women with a mean age of 25.9 years (SD= 7.1). The overall prevalence of
HIV was 5.9%. The prevalence of HIV was significantly higher among urban participants compared to their rural counterparts
(6.5 vs. 2.6%, p= 0.02). Almost one in five (19.6%) had never been tested for HIV prior to the study. Overall, 45.0% reported
ever using gender affirming hormones. More than one-third (39.1%) reported not using condoms in their last sex, 29.8% had
engaged in sex in exchange for money/gifts, and 14.0% reported that they had experienced at least one symptom of sexually
transmitted infections (STI) in the past year. About one in ten (10.1%) reported having used some form of amphetamine-type
stimulant drugs, while 6.5% reported having sex during or after using illicit drugs. A significant number of participants
experienced sexual abuse (39.2%), losing a job (24.3%), or physical abuse (23.6%) because of their transgender
identity. In addition, 82.9 and 88.9% would be willing to use the HIV self-test and pre-exposure prophylaxis (PrEP),
respectively, if they become available.
Conclusions: The high prevalence of HIV, STI, and related risk behaviors among transgender women in Cambodia is of
great concern, suggesting an urgent need to further expand tailored prevention interventions for this key population
focusing on individual, social, and structural drivers of HIV. HIV self-test and PrEP should be explored as a priority.
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Background
Transgender people are disproportionately affected by
HIV. The term “transgender” refers to a diverse range of
people whose gender identities differ from the sex
assigned to them at birth [1, 2]. A recent review by Baral
et al. shows that transgender women have a pooled HIV
prevalence of 19.1% [3], which is a 49-fold increased
odds of HIV infection compared with non-transgender
adults of reproductive age [2].
An increasing amount of epidemiological research has
highlighted factors that increase HIV vulnerability
among transgender people. Gender-based sexual vio-
lence that transgender people experience due to their
gender identity [4] increases risk of HIV infection [5].
Stigma prevents access to HIV services and care [6], and
is often associated with inconsistent condom use in anal
intercourse and sex work among transgender women
[7, 8]. Coinfection with perianal and other sexually
transmitted infections (STI) could also facilitate ac-
quisition and transmission of HIV [2, 9]. In addition,
recent studies suggest ways in which gender affirming
hormone use could impact HIV vulnerability [2]. Fur-
thermore, sex work is often associated with higher
prevalence of HIV among transgender people [10].
Whereas evidence showing the high vulnerability to
HIV of this population is increasing, transgender people
are generally underserved in national HIV responses
[11]. For instance, the majority of countries do not in-
clude transgender in the national HIV plans and strat-
egies [3]. This is often confounded by lack of adequate
data related to transgender people in many countries [2].
Population-based representative studies and routine sur-
veillance among transgender people are generally limited
globally [12]. In addition, there is a paucity of data to
guide clinical care of transgender people on antiretro-
viral and gender-affirming hormone therapies [13].
Furthermore, transgender people are often subsumed
under men who have sex with men (MSM) in many
countries [11, 14], which makes it difficult to provide
tailored responses to their behaviors and vulnerabilities
distinct from those of MSM [7, 11]. As a result, HIV
programs are not effective for this population [7].
Research and dissemination of findings related to
transgender people are required to inform policy and
programming for these particularly vulnerable people. In
this article, we present descriptive findings from a large-
scale national integrated biological and behavioral survey
among transgender women in Cambodia.
Methods
Study design, settings, and participants
The cross-sectional study was conducted between
December 2015 and February 2016 in 13 major sites (1
capital city and 12 provinces) of Cambodia. Respondent
Driven Sampling (RDS) method was used to recruit par-
ticipants with support from community-based imple-
menting partners of KHANA, the largest national NGO
providing community-based HIV prevention, care, and
support services in Cambodia [15]. Among the 13 study
sites, participants were recruited in 20 specific locations
(six locations in Phnom Penh and 14 locations in the
provinces). The number of the selected locations was de-
termined based on the proportion of the required sam-
ple size in each study site, and the estimated population
of transgender women in each site. Eligible participants
were individuals who: (1) were biologically male at birth
and self-identified as a woman, (2) were aged 18 years or
over, (3) reported having sex with at least one man in
the past 12 months, (5) could speak Khmer, and (6) were
able and willing to provide written consent to participate
in the study.
Four initial seeds were identified at each site by out-
reach workers from KHANA’s implementing partners
based on age (two seeds aged 18 to 24 and the other two
seeds aged 25 or older). These seeds had to meet the
eligibility criteria for participation and have an estab-
lished and large social network comprising about 10 or
more other transgender women in their given location.
Eligibility to participate as a seed was determined by the
leader of data collection team using a paper-based eligi-
bility form. Each seed was given three coupons and
asked to refer three additional transgender women.
US$2 was given to each seed for a successful referral.
Each seed was expected to extend to 3–6 “recruitment
waves” in each site. If the initial seeds did not recruit
participants or if enrollment was halted because all re-
cruitment chains had “dried up” (i.e. stopped recruiting),
additional seeds were selected based on the above cri-
teria. In total, 80 seeds were selected by the implement-
ing partners’ outreach workers initially.
Data collection and training
Data were collected by two teams with eight personnel
each that included one field supervisor, five interviewers,
one lab technician, and one counselor from the Provincial
AIDS and STI Program. The field supervisor conducted
eligibility screening of the participants. Each consenting
participant was assigned a unique personal identification
number, which was used to link all data collected from
each participant. The unique personal identification num-
ber was not linked with any personal data to protect confi-
dentiality. The counsellor then explained objectives of the
study in details, including the process of HIV testing, po-
tential risks and benefits of participation, and obtained
written informed consent. This was followed by HIV
counselling conducted by the counsellor, and HIV testing
conducted by the lab technician. Finger-prick-based HIV
testing was conducted using Determine™ test, according to
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the national protocol [16]. HIV testing and counseling
were performed in accordance with all applicable national
guidelines.
After the HIV test was conducted, an interviewer
administered the questionnaire in a private room using
an Android tablet. At the end of the interview, the
counsellor provided the HIV test result and post-test
counselling. Participants with a reactive result were re-
ferred to the nearest HIV clinic for a confirmatory test,
and were invited to come back to the implementing
partner site for ongoing support and follow-up services.
The field supervisor then provided a coupon incentive
to the participants. Each participant received US$4 in
cash to compensate for their time, and a package of
three condoms. This amount of incentive was deter-
mined reasonable and equivalent to a typical meal for
one person and the cost of transportation.
Prior to data collection, all interviewers and field su-
pervisors were trained for three days on data collection
methods and tool pretesting and reflection, to safeguard
consistency, quality, and validity of the data. The train-
ing included interview techniques, confidentiality, and
privacy, and provided opportunities for the study team
the opportunity to rehearse questionnaire administration
and other study procedures. During data collection, re-
view sessions with interviewers were conducted regularly
to review progress and communicate any problems or is-
sues which required solving.
Variables and measures
The questionnaire was developed using standardized
and validated tools adapted from previous literature,
the most recent Cambodia Demographic and Health
Survey, and other studies among HIV key populations
in Cambodia. It was initially developed in English and
then translated into Khmer, the national language of
Cambodia. Another translator then back-translated it
into English to ensure that the “content and spirit” of
every original item was maintained. Clear instructions
and explanations were included to avoid any confu-
sion during the interviews.
To design the study and develop the tools, consultative
meetings were held with representatives of transgender
women, community people, non-governmental organiza-
tions (NGOs), donor agencies, government officers, as
well as researchers and practitioners working on HIV
and AIDS in Cambodia. Prior to data collection, the
questionnaire was pretested to ensure that the wording
and contents of the questionnaire were culturally suit-
able, acceptable, and clearly understood by the study
participants before it was finalized. In the pilot study, we
conducted face-to-face interviews with 20 transgender
women recruited from Phnom Penh to assess the con-
tents, format, length, language, and appropriateness of
the questionnaire. Necessary modifications were made
based upon feedbacks from the pilot study and from the
consultative meetings. The final version of the question-
naire was used for the main data collection.
The questionnaire collected the following information:
(1) Socio-demographic characteristics; (2) transgender
identity and related experiences; (3) sexual behaviors
and condom use in different relationships; (4) accessibil-
ity to condoms and lubricants; (5) HIV/STI screening
and care seeking behaviors; (6) substance use (alcohol,
illicit drugs); and (7) experiences of stigma and discrim-
ination in communities and health facilities.
Data management and analyses
Data from the questionnaires collected via Android tablets
were transferred onto a secure server after completion of
each day of data collection. After synchronization, the data
were cleared from the tablet. At the conclusion of the
two-month data-collection, the data were downloaded
from the secure server, tabulated, and transcribed into a
Microsoft Excel format. Data were then imported into
STATA (Version 12.0) for analyses. Prior to the analyses,
data were weighted to account for the effect of RDS
method. Descriptive analyses were conducted to calculate
the counts and proportion (%) for categorical variables
and means with standard deviations (SD) for continuous
variables. Where applicable, Chi-square test or Student’s
t-test was used to compare between groups.
Ethical considerations
Participants were required to provide written consent
after being informed in details about the study objec-
tives, risk, and benefits. Participants were informed that
they could withdraw from the study at any time. Inter-
views and HIV testing and counseling were conducted at
private locations within drop-in centers, private houses,
or offices of KHANA’s implementing partners, and con-
fidentiality was ensured by assigning a personal identity
number (PIN) to each participant and removing all per-
sonal identifiers. The study protocol was approved by
the National Ethics Committee for Health Research
(NECHR) of the Ministry of Health, Cambodia (No. 420
NECHR) and FHI 360’s Protection of Human Subjects
Committee (PHSC No. 713897).
Results
Characteristics of the study participants
Characteristics of the study participants are shown in
Table 1. Of the 1,375 participants, majority (83.4%) were
urban dwelling, and 53.0% were younger than 25 years
old. Mean age of the respondents was 25.9 years (SD =
7.1). Two-thirds of the participants (68.6%) completed
high school, and 9.1% had higher education. Common
occupations of the participants were hair dressers/
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beauticians (35.1%), laborers/farmers (17.5%), and enter-
tainment workers (14.8%). More than one-third of the
participants (38.6%) reported their average monthly
income in the past six months of US$ 100–199, while
16.5% reported it to be more than US$ 300.
HIV prevalence
The overall prevalence of HIV was 5.9% (n = 81); of
whom, 52% (n = 42) were not aware of their HIV status
prior to the study. The highest prevalence of HIV was
found among transgender women in Banteay Meanchey
(11.7%) and Siem Reap (11.3%), followed by Phnom
Penh (6.5%) and Battambang (5.3%). Similar HIV preva-
lence rates were found in Kampong Speu (4.3%), Tbong
Khmum (4.2%), and Kandal (4.2%). No HIV-positive
cases were detected in Koh Kong, Prey Veng, and Svay
Rieng (Fig. 1). The prevalence of HIV was significantly
higher among transgender women living in urban com-
munities than among those living in rural communities
(6.5 vs. 2.6%, p = 0.02). The highest prevalence of HIV
was found among transgender women in the age group
of 35–44 years old (13.1%), followed by those in the age
group of >45 years old (11.4%). Transgender women in
the age group of younger than 25 years old had the low-
est HV prevalence rate at 3.0%.
Gender identity and affirming hormone use
Table 2 shows that 42.2% of the participants identified
themselves as female, while 57.2% identified as third
gender. In the Cambodian context, “third gender” refers
to transgender people (women or men). This term is
now considered discriminating and unspecific; and it
thus is not recommended for use in HIV or other related
programs. About half of them (48.0%) reported dressing
up as a woman all the time. Of total, 45.0% reported
ever used hormone or other substances for beauty pur-
poses such as pills (45.0%), injection (18.3%), and skin
patches (14.0%). The injections were mostly reported to
be performed by skilled personnel (67.8%), followed by
non-skilled personnel (25.7%), and self-injection (6.5%).
Of those who have injected the substances, 1.5% re-
ported ever sharing needles while injecting the sub-
stances, and 9.2% had ever had an operation to change
any part of their body to become more feminine.
Sexual behaviors
As shown in Table 3, 8.5% reported ever had sex with a
woman in their lifetime, and 2.2% reported ever had sex
with a woman in the past 12 months. Of those who
engaged in intercourse with a woman in the past
12 months, 66.7% reported having sex not in exchange
for money, and 33.3% reported both in exchange and
not in exchange for money.
Table 3 shows information about participants’ sexual
experiences with men. Nearly all respondents (97.9%)
have had sexual intercourse with a man. The majority
(87.5%) reported a receptive role, while only 2.2% re-
ported an insertive role, and 10.3% reported both roles.
In the past three months, 86.0% had anal sex with a
man, of which 61.9% used condom in their last sex.
Among all participants, 81.6% had sex not in exchange
for money/gifts, of which 62.1% reported not always
using condoms in the past three months by giving the
reasons that they were in relationship (62.8%); their
partners were not HIV/STI infected (31.0%); no condom
was available (27.1%); they felt better without condom






18– 24 729 (53.0)
25–34 503 (36.6)
35–44 99 (7.2)




Never married 1334 (97.2)
Refuse to answer 16 (1.2)
Formal education attained
Primary (0–6 years) 307 (22.3)
High school (7–12 years) 943 (68.6)
Higher education (>12 years) 125 (9.1)
Main occupations
Unemployed 64 (4.7)
Hair dresser/beautician 482 (35.1)
Office worker (government/private company staff) 50 (3.6)
Labor/farmer 241 (17.5)
Seller 149 (10.8)
Entertainment worker 203 (14.8)
Student 108 (7.9)
NGO staff 34 (2.5)
Other 44 (3.2)
Average monthly income in past six months (USD)
< 100 351 (25.6)
100–199 530 (38.6)
200–299 266 (19.3)
≥ 300 226 (16.5)
Abbreviations: NGO, non-governmental organization; USD, United States dollar;
IQR, interquartile range
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(20.9%); and their partners refused to use it (17.1%).
Among all participants, 29.8% had sex in exchange for
money/gifts, of which 40.0% reported not always using
condoms in the past three months by giving the reasons
that no condom was available (39.8%); they were in rela-
tionship (32.6%); their partners refused to use it (29.8%);
and they felt better without condom (21.6%).
Access to condoms and lubricants
Figure 2 shows the access to condoms and lubricant
in the past 12 months. The most commonly reported
sources of condoms and lubricant were friends/out-
reach workers (71.8 and 70.6% for condoms and
lubricant, respectively), followed by pharmacies/drug
stores/clinics (43.9 and 39.0% for condoms and lubri-
cant, respectively).
STI symptoms and treatment
Table 4 shows the experiences of STI symptoms and
treatment seeking behaviors among transgender women
in this study. Of the total survey sample, 14.0% reported
that they had experienced at least one STI symptom in
the past 12 months. The most commonly reported
symptoms were symptoms on the anus (6.1%). Of those
with the symptoms, 138 (71.1%) reported seeking treat-
ment for their most recent symptom from an NGO fa-
cility (21.5%), private pharmacy (16.4%), public facility
(16.4%), and private facility (14.9%).
HIV testing, treatment, and willingness to use PrEP
Table 5 shows that 19.6% had never been tested for HIV
before, while 44.3% had been tested within the past 6
months. Of those who had been tested and received re-
sults, 3.6% reported being HIV positive. Among those
who reported being HIV positive, 94.9% were currently
on ART. Majority of the testing (69.7%) were done at an
NGO facility.
Many participants (82.9%) said they were willing to
use the HIV self-test if it were available. When asked if
they had ever heard of pre-exposure prophylaxis (PrEP),
37.6% participants answered ‘Yes.’ Regarding the likeli-
ness of using PrEP, 88.9% said they would likely use it
and that they would prefer to access the PrEP at a local
NGO (53.5%) over other locations (Table 5).
Substance use
Table 6 depicts the reported alcohol and illicit drug use
among transgender women in this study. Of total, 75.9%
reported drinking at least one can of beer or a glass of
wine in the past 3 months. More than half (56.1%)
responded that this occurred less than once a month,
while 8.1% responded four or more times a week. Of
total, 10.1% reported having used some form of amphet-
amine-type stimulants (Yama, Crystal Ice, Ecstasy), while
Fig. 1 Prevalence of HIV among the study participants by study site





Third gender 786 (57.2)
Uncertain 8 (0.6)
Frequency of dressing up as a woman
All the time 660 (48.0)
Not all the time 715 (52.0)
Ever used hormone/non-hormone substances 618 (45.0)
Pill 561 (40.8)
Injection 252 (18.3)
Skin patches 192 (14.0)
How hormone/non-hormone substance hormone were injected
Self-injection 17 (6.5)
Injected by skilled personnel 177 (67.8)
Injected by non-skilled personnel 67 (25.7)
Ever shared needles when injecting beauty substances 20 (3.2)
Ever had operation to change any parts of your body
to become a woman
127 (9.2)
Abbreviations: NGO, non-governmental organization
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0.9% reported having used other drugs (marijuana, heroin,
etc.). Of total, 1.5% reported having injected some
form of illicit drugs in the past 3 months, and
6.5% reported having sex during or after using
illicit drugs.
Discrimination experiences
Figure 3 shows the discrimination experienced by trans-
gender women in this study because of their transgender
identity or gender presentation. Of total, 42.1% experi-
enced problems getting a job, whereas 24.3% experi-
enced problems losing a job. The next most common
discrimination experienced was sexual abuse or assault
(39.2%), while the least common form of discrimination
reported in this study were problems getting services
from an HIV prevention program (8.5%) and had prob-
lems getting health or medical services (9.1%).
Discussion
There is growing interest in understanding the epi-
demiology of HIV among transgender people. This
study set out to explore demographic, behavioral and
health-related characteristics of transgender women in
Cambodia. Results showed that the prevalence of HIV
was 5.9% among the sample. In addition, the results
provide useful data on high-risk sexual behaviors, STI
symptoms, substance use, HIV testing, discrimination
experiences, and willingness to use PrEP among this
population.
The HIV prevalence found in our study is slightly
higher than the 4.2% found by a recent study by
Weissman et al. [17], but both are significantly higher
than an earlier study conducted in 2010 which found a
prevalence of 2.6% among transgender women [18].
However, direct comparison of findings from this study
with those in the previous ones is difficult because of the
differences in characteristics of the samples and mea-
sures. Our study was conducted in 13 sites (one city and
12 provinces), while the study by Weissman et al. was
conducted in six sites [17] and the Bros Khmer study in
seven sites [18]. The timeframes used to measure key
variables, such as HIV testing and condom use, were
also not consistent. Studies from Cambodia have con-
sistently reported higher levels of HIV prevalence among
transgender people compared to MSM [17, 18], under-
scoring the importance of separating transgender people
Table 3 Sexual behaviors of the study participants with biological
women and men
Sexual behaviors Number (%)
Ever had sex with a woman (lifetime) 117 (8.5)
Ever had sex with a woman in the past 12 months 30 (25.6)
Type of female sexual partners in the past 12 months
Female commercial partners 0 (0.0)
Female non-commercial partners 20 (66.7)
Both (commercial/non-commercial) 10 (33.3)




Had anal sex with a man, past 3 months 1183 (86.0)
Median number of male partners in past 3 months (IQR) 3 (1–7)
Used condom at last anal sex 732 (61.9)
Anal sex with male non-commercial partners in past
3 months
1122 (85.7)
Median number of male non-commercial partners in
past 3 months (IQR)
3 (1–5)
Condom use in anal sex with male non-commercial
partner in past 3 months
Not always 697 (62.1)
Always 425 (37.9)
Reason for not using condoms with male non-commercial partner
in the past 3 months
We are in a relationship 438 (62.8)
He/she is not HIV/STI infected 216 (31.0)
Too high to use condom 37 (5.3)
No condom available 189 (27.1)
Feel better without condom 146 (20.9)
I am HIV-infected 2 (0.3)
I penetrated, so I am not at risk 4 (0.6)
Partner refused 119 (17.1)
Other 11 (1.6)
Had sex with a male commercial partner in the past
12 months
410 (29.8)
Median number of male commercial partners in the
past 3 months (IQR)
3 (1–8)
Condom use with male commercial partners in the past 3 months
Not always 164 (40.0)
Always 246 (60.0)
Reasons for not using condoms with male commercial partners
We are in a relationship 59 (32.6)
She is not HIV/STI infected 25 (13.8)
Too high to use condom 17 (9.4)
No condom available 72 (39.8)
Feel better without condom 39 (21.6)
Table 3 Sexual behaviors of the study participants with biological
women and men (Continued)
I penetrated, so I am not at risk 1 (0.6)
Partner refused 54 (29.8)
Other 7 (2.2)
Abbreviation: HIV, human immunodeficiency virus; IQR, interquartile range; STI,
sexually transmitted infection
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from MSM so as to have an accurate picture of HIV epi-
demic among this group.
Since 2013, transgender women have been recognized
as a separate population from MSM within the Standard
Operating Procedures of Boosted Continuum of Preven-
tion, Care and Treatment [19]. However, even within
transgender people, differences were noted in HIV
prevalence based on residence. The prevalence was sig-
nificantly higher among transgender women in urban
communities compared to those in rural areas, which
suggests the need to better focus on cities and urban
areas. These findings also buttress calls for geographic
localization of HIV prevention efforts [10], given that
HIV rates were much higher in Banteay Meanchey, Siem
Reap, Phnom Penh, and Battambang provinces com-
pared to other provinces.
An important implication from the study was related
to combination prevention. The majority of the partici-
pants were sexually active, with 97.9% reporting having
intercourse with men, mostly anal sex. However, a sig-
nificant number of these did not use condoms consist-
ently. Given the high prevalence of HIV in this group,
these findings suggest that expansion of HIV prevention
interventions for this group is warranted. This is particu-
larly relevant given that two thirds of the participants
Fig. 2 Access to condoms and lubricant by type of facility in the past 12 months
Table 4 STI symptoms and treatment experiences of the study
participants
Variables Number (%)
STI symptoms experienced in the past 12 months 193 (14.0)
Cut or sores in the genital area 46 (3.4)
Swelling in the genital area 16 (1.2)
Abnormal urethral discharge 36 (2.6)
Symptoms on the anus 84 (6.1)
Symptom in the mouth/throat 39 (2.8)
Facility where treatment for the most recent STI symptoms
was received
Did not seek treatment 57 (29.2)
Private pharmacy 32 (16.4)
Private facility 29 (14.9)
Public facility 32 (16.4)
NGO facility 42 (21.5)
Traditional healer 3 (1.5)
Abbreviations: NGO, non-governmental organization; STI, sexually transmitted infection
Table 5 HIV testing experience, status awareness, and willingness
to use PrEP
Variables Number (%)
Ever been tested for HIV
Never 269 (19.6)
1–3 months 431 (31.4)
4–6 months 178 (12.9)
7–12 months 346 (25.1)
> 12 months ago 151 (11.0)
Received results from the last HIV test 1079 (97.5)
Currently on ART 37 (94.9)
Place of the most recent HIV test
Private facilities 119 (10.8)
Public facilities 208 (18.8)
NGO facilities/community based HIV testing 771 (69.7)
Other 9 (0.8)
Willingness to use HIV self-test if it were available 842 (82.9)
Ever heard of Pre-exposure prophylaxis (PrEP) 359 (37.6)
Likeliness of using PrEP
Unlikely 79 (8.3)
Likely 849 (88.9)
Not sure 27 (2.8)
Preferred place to access PrEP if available
Local NGOs 511 (53.5)
ART clinic 148 (15.5)
Pharmacy 270 (28.3)
Other 26 (2.7)
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus;
NGO, non-governmental organization; PrEP, pre-exposure prophylaxis
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had not heard of PrEP, but 88.9% were willing to use it.
Combined with the high proportion (94.9%) of HIV
positive participants who were on ART, these findings
suggest that provision of PrEP could reduce incidence of
HIV among this population. The high prevalence of sex
work in exchange of money among this sample provides
another reason to consider PrEP for transgender sex
workers. Other studies have highlighted the heightened
vulnerability and the needs for better tailored interven-
tions for transgender sex workers [20, 21].
The low rate of HIV testing observed among trans-
gender women in this study is of concern and suggests
that significant effort is required to increase HIV testing
uptake. In particular, HIV education and benefit of HIV
testing should be widely promoted among this popula-
tion. The lack of HIV awareness could influence HIV
sexual behaviors, including the use of condoms, or com-
mercial sex [22]. In addition, HIV testing is the first step
towards early access to treatment, which also has high
preventive benefits. Results from this study indicate that
participants were willing to consider HIV self-testing,
which could provide additional flexibility in access to
testing. HIV self-testing has potential to reach individ-
uals who are least likely to seek testing in a public clinic,
hospital, voluntary confidential counseling and testing
center (VCCT), or with a community-based non-
governmental organization. Results from other settings
indicate that self-testing may be acceptable to trans-
gender people [23] and should be made available while
considering issues related to confirmation and linkage to
care, cost [24], quality assurance, as well as support
needs of different potential users of self-tests [25].
Our study indicates that 6.5% of the participants re-
ported having sex during or after using illicit drugs, so
called “Chem sex”, which may increase sexual risk taking
[26, 27]. Furthermore, 45% of the participants had ever
used gender affirming hormones, which included through
injections in 18% of the cases. Our results also indicate
that the injecting practices were often unsafe (by self-
injection or non-skilled providers) and included sharing of
needles. Therefore, HIV prevention efforts should explore
provision of PrEP and education regarding the use of
drugs during sex, while considering how safe needle
exchange interventions can be integrated for those who
inject drugs or hormones.
Our study shows the importance of community-based
outreach services in increasing access to HIV prevention
services. Peers and outreach workers were the sources of
condoms for 70% of the participants. In addition, find-
ings related to STI suggested that the majority of the
participants that experienced STI symptoms shunned
public facilities as a source of treatment, with the major-
ity seeking health care from NGO or private facilities
and pharmacies. Furthermore, the majority of partici-
pants accessed HIV testing from community-based
NGOs. These preferences may be related to the demand
Table 6 Substance use among the study participants
Variables Number (%)
Drank at least one can of beer or glass of wine in
the past 3 months
1042 (75.9)
Frequency of having more than 5 drinks in one day
in the past 3 months
Never more than five drinks 336 (24.4)
Less than once a month 771 (56.1)
1–3 times a week 157 (11.4)
4 or more times a week 111 (8.1)
Ever used illicit drugs in the past 12 months
Never 1224 (89.0)
Yes, ATS (Yama, crystal ice, ecstasy) 139 (10.1)
Other drugs (marijuana, heroin, etc.) 12 (0.9)
Ever injected any illicit drugs in the past 3 months 20 (1.5)
Ever had sex during/after using illicit drugs in the
past 3 months
89 (6.5)
Abbreviation: ATS, Amphetamine-type stimulants
Fig. 3 Discrimination experiences of the study participants
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creation, peer-support building or less stigmatizing na-
ture of community-based organizations and services in
the study context. Evidence from other contexts indicate
that when services, often community-based, are non-
stigmatizing, gender-affirming, trans-specific and lever-
aged on local peers and resources, transgender people
access them [28–30].
Conversely, these findings highlight a need to better
understand how the capacity of public health facilities to
provide friendly services to transgender people can be
strengthened. In 2014, the World Health Organization
released a global guidance on HIV programming for key
populations, including transgender people [31]. More re-
cently, implementation tools developed to assist the
provision of comprehensive community-led responses
for transgender people have been launched [32]. In
Cambodia, these guidelines and implementation tools
need to be adapted and implemented.
Stigma and discrimination are powerful drivers of
inequitable access to HIV and health services among
transgender [6, 33] and other [34] populations. Yet HIV
cannot be eliminated unless transgender persons can
have universal access to HIV and health services. Our
study shows that a significant number of transgender
women experienced discrimination based on their trans-
gender identity, including problems getting services from
an HIV prevention program (8.5%) and other health and
medical services (9.1%). In a similar Cambodian study,
54.8% of participants reported having experienced discrim-
ination related to transgender identity in their lifetime [17].
Consequently, significant effort will be required to sensitize,
and train health care providers so that they provide appro-
priate care with non-judgmental attitudes to transgender
women. General practitioners, nurses and non-clinical
health professionals working in public hospitals and HIV
clinics need to be equipped with appropriate clinical skills
including clerking, counselling, and examination skills so as
to provide appropriate care to transgender women. This is
particularly important because 39.2% of the partici-
pants reported experiencing sexual abuse or assault,
which can increase HIV vulnerability and requires ac-
cess to health and medical services.
More broadly, the intersectionality of multiple dele-
terious determinants of health, including drug use or
abuse, violence or stigmatization, poor mental health,
internalized transphobia, and economic hardships may
potentiate HIV vulnerability [35], reduce uptake of
services [34], and contribute to poor HIV treatment out-
comes [2] among different populations, including trans-
gender people. Hence, multi-sectoral interventions to
mitigate these complex interacting syndemic factors in
an integrated fashion are required. Importantly, this
approach should include sectors beyond physical health,
such as mental health, legal, policing, and social
protection sectors, to mitigate arbitrary arrests [6, 36],
lack of employment [37], criminalization, victimization
[38], violence [5, 38], and other structural drivers of vul-
nerability to HIV among this population.
Findings from this study should be cautiously inter-
preted in light of the design, recruitment, methods of
data collection, and sample profile. As this was a cross-
sectional study, it captures a snapshot view of the popu-
lation studied, and may not document changes in
measured variables over time. Our study sample had
relatively educated participants, which may not be repre-
sentative of all transgender women in the country, and
were initially recruited from those who had some con-
tact with outreach workers. Future studies should be
more cautious about selecting seeds that are more repre-
sentative of sub-populations of transgender women by
considering their socio-demographic characteristics such
as education levels, occupations, incomes, etc. Sexual
behaviors and other sensitive information were col-
lected from the participants through a self-reported
questionnaire, which is often at high risk of bias [39].
Despite these limitations, this paper provides import-
ant information that can be built upon to inform pro-
gramming and policy.
Conclusions
There is a growing interest in understanding the epi-
demiology of HIV among transgender people. This
article presents findings from a cross-sectional study
among transgender women in Cambodia, showing the
high HIV prevalence and risky sexual behaviors among
the participants. These findings call for an urgent need
to further expand and refine prevention interventions
for transgender women, focusing on individual, social,
and structural domains of vulnerability. This study
therefore should inform policy and programmatic inter-
ventions to promote health and prevent the HIV vulner-
ability among transgender people in Cambodia.
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